Uptravi
Ended Awarded Last action
- Contract number
- 36C26024F0035
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $258,434
Award facts
- Contract value 100% obligated
- $258,434.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Normandy, MO 63121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $5,004 | |
| Funding Only Action | $59,631 | |
| Original award | $193,800 |
About this award
This is a delivery order awarded by the Veterans Integrated Service Network 20 (VISN 20), part of the U.S. Department of Veterans Affairs (VA), to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The $258,434 firm fixed-price contract is for the drug Uptravi, a therapy for pulmonary arterial hypertension.
The contract is issued under Actelion's Federal Supply Schedule (FSS-61-IB) contract with the VA for Pharmaceuticals and Drugs, which has a total ceiling value of $219,108,390 and runs from August 1, 2024 to July 31, 2029. Actelion also holds two Blanket Purchase Agreements (BPAs) with the VA National Acquisition Center, valued at $118.5 million and $83.5 million respectively, to provide a range of Actelion's pulmonary hypertension medications to VA medical centers and other federal healthcare providers.
This contract does not utilize any small business set-aside designations, as Actelion Pharmaceuticals US, Inc. is a large, for-profit pharmaceutical manufacturer. The primary funding for this award comes from the VA's Veterans Health Administration.
Quick answers
Who was awarded contract 36C26024F0035?
36C26024F0035 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C26024F0035 worth?
The government has obligated $258,434 on 36C26024F0035.
Is contract 36C26024F0035 an order under another contract?
Yes. 36C26024F0035 is a delivery order under 36F79719D0142, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0035 competed?
The extent of competition for 36C26024F0035 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award